Evidence map›Paper›PMID 22798322›Full record

Trial reportAmerican journal of respiratory and critical care medicine2012

Effect of vitamin D and inhaled corticosteroid treatment on lung function in children.

Ann Chen Wu, Kelan Tantisira, Lingling Li, Anne L Fuhlbrigge, Scott T Weiss, Augusto Litonjua, Childhood Asthma Management Program Research Group

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in American journal of respiratory and critical care medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 5 pooled it
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 5 syntheses or guidelines pooled it, 135 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Association of free vitamin DAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2018
    Trial
  8. Trial
  9. 25-hydroxy vitamin D levels are associated with childhood asthma in a population-based study in Peru.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2015
    Trial
  10. Trial
  11. Trial
  12. Impact of Vitamin D3 Supplementation on Symptom Severity & IgE in Persistent Allergic Rhinitis.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2025
    Article
  13. Article
  14. The Role of Vitamins in the Pathogenesis of Asthma.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Asthma and vitamin D in Brazilian adolescents: Study of Cardiovascular Risks in Adolescents (ERICA).Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2021
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ann Chen WuCenter for Child Health Care Studies, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA 02215-5301, USA. ann.wu@childrens.harvard.edu
Kelan Tantisira
Lingling Li
Anne L Fuhlbrigge
Scott T Weiss
Augusto Litonjua
Childhood Asthma Management Program Research Group
Brigham and Women's Hospital · USHarvard University · USBoston Children's Hospital · US

Funding

ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI KOSMISKI, LISA A. · 1985 to 2008
$52.6M
THE PHARMACOGENETICS OF ASTHMA TREATMENTU01HL065899 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI TANTISIRA, KELAN G, WEISS, SCOTT T · 2000 to 2014
$38.5M
YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMESM01RR000036 · NCRR · WASHINGTON UNIVERSITY · PI NEWCOMER, JOHN W. · 1985 to 2007
$25.4M
ZINC THERAPY FOR SCLERODERMA--PHASE I STUDYM01RR002719 · NCRR · JOHNS HOPKINS UNIVERSITY · PI EARLEY, CHRISTOPHER J · 1986 to 2007
$20.2M
CAMPCS/3U01HL075408 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI TONASCIA, JAMES A · 2003 to 2010
$4.9M
CAMP Continuation Study/Phase 3U01HL075419 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI FUHLBRIGGE, ANNE L · 2003 to 2010
$2.0M
CAMP Continuation Study/Phase 3U01HL075409 · NHLBI · ASTHMA, INC. · PI WILLIAMS, PAUL V · 2003 to 2010
$1.6M
CAMP Continuation Study/Phase 3U01HL075417 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ADKINSON, N FRANKLIN · 2003 to 2010
$1.4M
CAMP Contiunation Study/Phase 3U01HL075416 · NHLBI · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J. · 2003 to 2010
$1.4M
CAMP Continuation Study/Phase 3U01HL075415 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZEIGER, ROBERT S · 2003 to 2010
$1.3M
CAMP Continuation Study/Phase 3U01HL075232 · NHLBI · WASHINGTON UNIVERSITY · PI STRUNK, ROBERT · 2003 to 2010
$1.3M
CAMP Continuation Study/Phse 2 (CAMPCS/2)U01HL075420 · NHLBI · UNIVERSITY OF NEW MEXICO · PI RAISSY, HENGAMEH H · 2003 to 2010
$1.1M
NCRR NIH HHS M01 RR000036NCRR NIH HHS M01 RR000051NCRR NIH HHS M01RR00051NCRR NIH HHS M01 RR002719NCRR NIH HHS M01RR0099718-24NCRR NIH HHS M01RR02719-14NCRR NIH HHS RR00036NHLBI NIH HHS K08 HL088046NHLBI NIH HHS K08HL088046NHLBI NIH HHS N01 HR016044NHLBI NIH HHS N01-HR-16044NHLBI NIH HHS N01-HR-16045NHLBI NIH HHS N01-HR-16046NHLBI NIH HHS N01-HR-16047NHLBI NIH HHS N01-HR-16048NHLBI NIH HHS N01-HR-16049NHLBI NIH HHS N01-HR-16050NHLBI NIH HHS N01-HR-16051NHLBI NIH HHS N01-HR-16052NHLBI NIH HHS R21 HL089842NHLBI NIH HHS U01 HL065899NHLBI NIH HHS U01HL065899NHLBI NIH HHS U01 HL075232NHLBI NIH HHS U01HL075232NHLBI NIH HHS U01 HL075407NHLBI NIH HHS U01HL075407NHLBI NIH HHS U01 HL075408NHLBI NIH HHS U01HL075408NHLBI NIH HHS U01 HL075409NHLBI NIH HHS U01HL075409NHLBI NIH HHS U01 HL075415NHLBI NIH HHS U01HL075415NHLBI NIH HHS U01 HL075416NHLBI NIH HHS U01HL075416NHLBI NIH HHS U01 HL075417NHLBI NIH HHS U01HL075417NHLBI NIH HHS U01 HL075419NHLBI NIH HHS U01HL075419NHLBI NIH HHS U01 HL075420NHLBI NIH HHS U01HL075420
6 · The paper itself

Abstract

rationaleLow vitamin D levels are associated with asthma and decreased airway responsiveness. Treatment with inhaled corticosteroids improves airway responsiveness and asthma control.

objectivesTo assess the effect of vitamin D levels on prebronchodilator FEV(1), bronchodilator response, and responsiveness to methacholine (PC(20), provocative concentration of methacholine producing a 20% decline in FEV(1)) in patients with asthma treated with inhaled corticosteroids.

methodsWe measured 25-hydroxyvitamin D levels in the serum of children with persistent asthma at the time of enrollment in the Childhood Asthma Management Program. We divided subjects into the vitamin D sufficiency (>30 ng/ml), insufficiency (20-30 ng/ml), and deficiency (<20 ng/ml) groups. Covariates included age, treatment, sex, body mass index, race, history of emergency department visits, hospitalizations, and season that vitamin D specimen was drawn. Our main outcome measures were change in prebronchodilator FEV(1), bronchodilator response, and PC(20) from enrollment to 8-12 months. MEASUREMENTS AND MAIN

resultsOf the 1,024 subjects, 663 (65%) were vitamin D sufficient, 260 (25%) were insufficient, and 101 (10%) were deficient. Vitamin D-deficient subjects were more likely to be older, African American, and have a higher body mass index compared with the vitamin D-sufficient and insufficient subjects. In the inhaled corticosteroid treatment group, prebronchodilator FEV(1) increased from randomization to 12 months by 140 ml in the vitamin D-deficient group and prebronchodilator FEV(1) increased by 330 ml in the vitamin D insufficiency group and by 290 ml in the vitamin D sufficiency group (P = 0.0072), in adjusted models.

conclusionsIn children with asthma treated with inhaled corticosteroids, vitamin D deficiency is associated with poorer lung function than in children with vitamin D insufficiency or sufficiency.

Indexed as

Administration, InhalationAsthmaBudesonideChildChild, PreschoolFemaleFollow-Up StudiesHumansMaleMonitoring, PhysiologicNedocromilProspective StudiesReference ValuesRespiratory Function TestsRisk AssessmentSeverity of Illness IndexBudesonideNedocromilVitamin D

Identifiers

PMID22798322
PMCPMC3480528
OpenAlexW1995560331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.